Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

Isabel Bergeri(World Health Organization), Brianna Cheng(University of Toronto), Hannah C. Lewis(World Health Organization), Joseph Okeibunor(World Health Organization Regional Office for Africa), Tasnim Azim(International Centre for Diarrhoeal Disease Research), Lubna Al Ariqi(World Health Organization Regional Office for the Eastern Mediterranean), David L. Buckeridge(McGill University), Marta Valenciano(World Health Organization), Mairead Whelan(University of Calgary), Matthew P. Cheng(McGill University Health Centre), Niklas Bobrovitz(University of Calgary), Xiaomeng Ma(University of Toronto), Aisling Vaughan(World Health Organization Regional Office for Europe), Mercedes Yanes‐Lane(McGill University), Andrea Vicari(World Health Organization Regional Office for the Americas), Christian Cao(University of Calgary), Anthony Nardone(World Health Organization), Tingting Yan(University of Toronto), Linh‐Vi Le(World Health Organization Regional Office for the Western Pacific), Pushpa Ranjan Wijesinghe(World Health Organization Regional Office for South-East Asia), Jesse Papenburg(McGill University Health Centre), Maria D. Van Kerkhove(World Health Organization), Arash Rashidian(Tehran University of Medical Sciences), Lorenzo Subissi(World Health Organization - Pakistan), Richard Pebody(World Health Organization Regional Office for Europe), Zihan Li(University of Calgary), Rahul K. Arora(University of Calgary), David A. Clifton(University of Oxford)
PLoS Medicine
November 10, 2022
Cited by 298


Related Papers